Premium
Topical corticosteroids in psoriasis: strategies for improving safety
Author(s) -
Horn EJ,
Domm S,
Katz HI,
Lebwohl M,
Mrowietz U,
Kragballe K
Publication year - 2010
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2009.03358.x
Subject(s) - medicine , psoriasis , dermatology , safety profile , adverse effect , intensive care medicine , pharmacology
Corticosteroids are a mainstay of topical therapy for psoriasis. While efficacious and relatively safe when used carefully, the potential for side effects, notably skin atrophy and adrenal suppression, have been associated with excesses in potency, prolonged or widespread use. The International Psoriasis Council Working Group on Topical Therapy has reviewed the efficacy and safety of topical corticosteroids and recommends strategies for safe, long‐term use of these agents.